Professor Paul Enck and his group at University of Tübingen (Germany) and the Alimentary Health Group1 have conducted a new clinical study, which has just been published online in the American Journal of Gastroenterology.
Professor Enck’s group are renowned researchers in the gut-brain axis.
1 - The Alimentary Health Group is a parent company of PrecisionBioticsTM
‘As researchers in the placebo effect, we have been sceptical about many of the claims made about bacterial cultures and the gut-brain axis. We have significant experience in the placebo effect and so our team designed a comprehensive study to assess this strain.
We think the results are novel and innovative and provide a scientific basis to assess the true impact of specific bacterial strains on the brain.’